 Julie Haines
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 16 | 2019 | 652 | 2.410 |
Why?
| | Erythrocytes | 12 | 2019 | 673 | 1.900 |
Why?
| | Cysteine | 8 | 2019 | 195 | 1.570 |
Why?
| | Nitrogen Oxides | 6 | 2014 | 52 | 1.460 |
Why?
| | Blood Preservation | 9 | 2019 | 271 | 1.450 |
Why?
| | Metabolome | 11 | 2019 | 339 | 1.410 |
Why?
| | Oxidation-Reduction | 13 | 2019 | 1031 | 0.790 |
Why?
| | Nitric Oxide Donors | 2 | 2012 | 19 | 0.760 |
Why?
| | Phosphines | 4 | 2014 | 17 | 0.740 |
Why?
| | Peroxiredoxins | 3 | 2018 | 24 | 0.740 |
Why?
| | Sulfenic Acids | 3 | 2016 | 7 | 0.690 |
Why?
| | Hydrogen Peroxide | 3 | 2018 | 317 | 0.670 |
Why?
| | Proteins | 5 | 2016 | 944 | 0.670 |
Why?
| | Mass Spectrometry | 7 | 2019 | 717 | 0.630 |
Why?
| | Erythrocyte Transfusion | 4 | 2019 | 182 | 0.600 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 11 | 0.590 |
Why?
| | Hydroxylamine | 1 | 2017 | 7 | 0.570 |
Why?
| | Glycolysis | 7 | 2019 | 314 | 0.570 |
Why?
| | Retinal Detachment | 1 | 2018 | 58 | 0.560 |
Why?
| | Vitreous Body | 1 | 2018 | 109 | 0.550 |
Why?
| | Diabetic Retinopathy | 1 | 2018 | 179 | 0.510 |
Why?
| | Proteome | 2 | 2018 | 440 | 0.500 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2019 | 205 | 0.490 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2019 | 596 | 0.470 |
Why?
| | Chondrocytes | 2 | 2018 | 205 | 0.470 |
Why?
| | Blood Proteins | 1 | 2017 | 245 | 0.460 |
Why?
| | Neoplastic Stem Cells | 2 | 2019 | 378 | 0.460 |
Why?
| | Proteomics | 4 | 2018 | 1058 | 0.460 |
Why?
| | Succinic Acid | 4 | 2018 | 39 | 0.450 |
Why?
| | Plasma | 3 | 2019 | 206 | 0.430 |
Why?
| | Oxidative Phosphorylation | 3 | 2019 | 188 | 0.420 |
Why?
| | Extracellular Matrix | 1 | 2017 | 508 | 0.420 |
Why?
| | Triazenes | 1 | 2012 | 4 | 0.410 |
Why?
| | Lipids | 2 | 2019 | 628 | 0.400 |
Why?
| | Oxidative Stress | 5 | 2019 | 1264 | 0.390 |
Why?
| | Sulfones | 1 | 2012 | 108 | 0.380 |
Why?
| | Cardiotonic Agents | 1 | 2012 | 126 | 0.380 |
Why?
| | Sulfhydryl Compounds | 2 | 2014 | 187 | 0.380 |
Why?
| | Amino Acids | 3 | 2019 | 487 | 0.370 |
Why?
| | Shock, Hemorrhagic | 3 | 2018 | 165 | 0.360 |
Why?
| | Stomach Ulcer | 1 | 2011 | 11 | 0.360 |
Why?
| | Indomethacin | 1 | 2011 | 79 | 0.350 |
Why?
| | Macrophages | 3 | 2018 | 1489 | 0.350 |
Why?
| | Hydroxamic Acids | 1 | 2011 | 88 | 0.350 |
Why?
| | Prodrugs | 1 | 2011 | 48 | 0.340 |
Why?
| | Mitochondria | 3 | 2017 | 875 | 0.340 |
Why?
| | Energy Metabolism | 5 | 2019 | 875 | 0.330 |
Why?
| | Purines | 3 | 2018 | 172 | 0.330 |
Why?
| | Heart | 2 | 2019 | 645 | 0.330 |
Why?
| | Lipid Metabolism | 3 | 2019 | 503 | 0.330 |
Why?
| | Electron Transport Complex II | 1 | 2019 | 25 | 0.310 |
Why?
| | Animals | 25 | 2019 | 35409 | 0.310 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 485 | 0.300 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2018 | 18 | 0.300 |
Why?
| | Nitric Oxide | 2 | 2012 | 896 | 0.300 |
Why?
| | Organogenesis | 1 | 2019 | 56 | 0.300 |
Why?
| | Lung | 3 | 2019 | 3940 | 0.300 |
Why?
| | Gluconates | 1 | 2018 | 5 | 0.300 |
Why?
| | Antacids | 1 | 2018 | 16 | 0.290 |
Why?
| | Rejuvenation | 1 | 2018 | 18 | 0.290 |
Why?
| | Guanosine | 1 | 2018 | 41 | 0.290 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 40 | 0.290 |
Why?
| | Tracheal Stenosis | 1 | 2018 | 28 | 0.290 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 340 | 0.280 |
Why?
| | Protein Processing, Post-Translational | 3 | 2018 | 457 | 0.280 |
Why?
| | Interleukin-1beta | 2 | 2018 | 369 | 0.280 |
Why?
| | Glycogen | 1 | 2017 | 55 | 0.280 |
Why?
| | Cryopreservation | 2 | 2018 | 94 | 0.280 |
Why?
| | Fatty Acids | 2 | 2019 | 427 | 0.270 |
Why?
| | Airway Obstruction | 1 | 2019 | 154 | 0.270 |
Why?
| | Reactive Oxygen Species | 6 | 2019 | 592 | 0.270 |
Why?
| | Isotope Labeling | 2 | 2017 | 74 | 0.260 |
Why?
| | Liver | 3 | 2018 | 1839 | 0.260 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 95 | 0.260 |
Why?
| | High-Throughput Screening Assays | 2 | 2019 | 139 | 0.260 |
Why?
| | Wounds and Injuries | 3 | 2018 | 711 | 0.260 |
Why?
| | Iron | 1 | 2018 | 285 | 0.260 |
Why?
| | Calpain | 1 | 2016 | 57 | 0.250 |
Why?
| | Troponin T | 1 | 2016 | 57 | 0.250 |
Why?
| | Blood Pressure | 1 | 2012 | 1736 | 0.240 |
Why?
| | Humans | 37 | 2019 | 129847 | 0.240 |
Why?
| | Cholestasis | 1 | 2018 | 232 | 0.240 |
Why?
| | src-Family Kinases | 1 | 2016 | 95 | 0.240 |
Why?
| | Temperature | 1 | 2018 | 635 | 0.230 |
Why?
| | Calcium Channels, L-Type | 1 | 2016 | 117 | 0.230 |
Why?
| | Cycloparaffins | 1 | 2014 | 2 | 0.230 |
Why?
| | Fetus | 1 | 2019 | 782 | 0.220 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2014 | 11 | 0.220 |
Why?
| | Acute Lung Injury | 1 | 2017 | 280 | 0.220 |
Why?
| | NF-kappa B | 1 | 2018 | 666 | 0.220 |
Why?
| | Dendritic Cells | 1 | 2017 | 481 | 0.220 |
Why?
| | Cells | 1 | 2014 | 24 | 0.220 |
Why?
| | Peptide Fragments | 2 | 2016 | 695 | 0.220 |
Why?
| | Dithiothreitol | 1 | 2013 | 17 | 0.220 |
Why?
| | Osteoarthritis | 1 | 2016 | 168 | 0.210 |
Why?
| | Nucleic Acids | 1 | 2014 | 61 | 0.210 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2014 | 180 | 0.210 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 313 | 0.200 |
Why?
| | Cartilage, Articular | 1 | 2016 | 292 | 0.190 |
Why?
| | Biomarkers | 5 | 2019 | 3971 | 0.190 |
Why?
| | Glucose | 2 | 2018 | 1003 | 0.190 |
Why?
| | DNA Damage | 1 | 2014 | 383 | 0.180 |
Why?
| | Biomedical Research | 1 | 2017 | 640 | 0.180 |
Why?
| | Disease Models, Animal | 7 | 2019 | 4077 | 0.180 |
Why?
| | Oxidants | 2 | 2019 | 109 | 0.180 |
Why?
| | Mice | 11 | 2019 | 16983 | 0.170 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 549 | 0.170 |
Why?
| | S-Nitrosothiols | 1 | 2010 | 5 | 0.170 |
Why?
| | S-Nitrosoglutathione | 1 | 2010 | 8 | 0.170 |
Why?
| | Hemeproteins | 1 | 2010 | 7 | 0.170 |
Why?
| | Molecular Structure | 3 | 2012 | 483 | 0.170 |
Why?
| | Models, Biological | 1 | 2017 | 1724 | 0.170 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 5468 | 0.160 |
Why?
| | Kinetics | 3 | 2014 | 1645 | 0.160 |
Why?
| | Biocatalysis | 2 | 2014 | 68 | 0.160 |
Why?
| | Leukopoiesis | 1 | 2019 | 11 | 0.160 |
Why?
| | NADPH Oxidase 2 | 1 | 2019 | 38 | 0.160 |
Why?
| | Myeloid Progenitor Cells | 1 | 2019 | 17 | 0.160 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.150 |
Why?
| | Cardio-Renal Syndrome | 1 | 2019 | 12 | 0.150 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 21 | 0.150 |
Why?
| | Cell Self Renewal | 1 | 2019 | 53 | 0.150 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2014 | 140 | 0.150 |
Why?
| | Asparagine | 1 | 2018 | 30 | 0.150 |
Why?
| | Xanthine | 1 | 2018 | 7 | 0.150 |
Why?
| | Blood Banks | 1 | 2018 | 40 | 0.150 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 174 | 0.150 |
Why?
| | Aspartic Acid | 1 | 2018 | 80 | 0.150 |
Why?
| | Arousal | 1 | 2019 | 150 | 0.150 |
Why?
| | Proteostasis | 1 | 2018 | 27 | 0.140 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 11 | 0.140 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 18 | 0.140 |
Why?
| | Methods | 1 | 2017 | 64 | 0.140 |
Why?
| | Hemoglobin A | 1 | 2017 | 22 | 0.140 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.140 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.140 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 18 | 0.140 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.140 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2017 | 17 | 0.140 |
Why?
| | Aging | 2 | 2018 | 1774 | 0.140 |
Why?
| | Benzothiazoles | 1 | 2017 | 32 | 0.140 |
Why?
| | Pyruvate Kinase | 1 | 2017 | 26 | 0.140 |
Why?
| | Sphingosine | 1 | 2017 | 40 | 0.140 |
Why?
| | Sciuridae | 1 | 2019 | 146 | 0.140 |
Why?
| | Thiadiazoles | 1 | 2017 | 25 | 0.140 |
Why?
| | fms-Like Tyrosine Kinase 3 | 1 | 2017 | 47 | 0.140 |
Why?
| | Lysophospholipids | 1 | 2017 | 72 | 0.140 |
Why?
| | Solubility | 1 | 2017 | 232 | 0.140 |
Why?
| | Rabbits | 2 | 2019 | 778 | 0.140 |
Why?
| | Phenylurea Compounds | 1 | 2017 | 88 | 0.130 |
Why?
| | Models, Molecular | 3 | 2018 | 1488 | 0.130 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 83 | 0.130 |
Why?
| | Signal Transduction | 4 | 2018 | 4935 | 0.130 |
Why?
| | Leukemia | 1 | 2019 | 230 | 0.130 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.130 |
Why?
| | Fibronectins | 2 | 2018 | 127 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 528 | 0.130 |
Why?
| | Extracellular Matrix Proteins | 1 | 2017 | 144 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 40 | 0.130 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 338 | 0.130 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2018 | 585 | 0.130 |
Why?
| | Lactic Acid | 1 | 2018 | 304 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2018 | 272 | 0.130 |
Why?
| | Adenosine Triphosphate | 2 | 2019 | 482 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 117 | 0.130 |
Why?
| | Muscle, Skeletal | 1 | 2016 | 1644 | 0.120 |
Why?
| | Apolipoproteins | 1 | 2015 | 38 | 0.120 |
Why?
| | Esters | 2 | 2011 | 74 | 0.120 |
Why?
| | Workflow | 1 | 2017 | 157 | 0.120 |
Why?
| | Ischemia | 1 | 2019 | 405 | 0.120 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 85 | 0.120 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 426 | 0.120 |
Why?
| | Inflammation Mediators | 2 | 2019 | 505 | 0.120 |
Why?
| | Cyclohexanones | 2 | 2016 | 9 | 0.120 |
Why?
| | Protein Stability | 2 | 2016 | 162 | 0.110 |
Why?
| | Healthy Volunteers | 2 | 2019 | 201 | 0.110 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2018 | 32 | 0.110 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 253 | 0.110 |
Why?
| | Peroxiredoxin III | 1 | 2013 | 1 | 0.110 |
Why?
| | Amino Acid Sequence | 2 | 2018 | 2057 | 0.110 |
Why?
| | Time Factors | 4 | 2019 | 6550 | 0.110 |
Why?
| | Sulfinic Acids | 1 | 2013 | 7 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2403 | 0.110 |
Why?
| | Sulfonamides | 2 | 2018 | 497 | 0.110 |
Why?
| | Nitrogen Isotopes | 2 | 2017 | 58 | 0.110 |
Why?
| | Disulfides | 1 | 2013 | 97 | 0.100 |
Why?
| | Carbon Isotopes | 2 | 2017 | 127 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 371 | 0.100 |
Why?
| | Half-Life | 1 | 2012 | 162 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 503 | 0.100 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2017 | 541 | 0.090 |
Why?
| | Enzyme Activation | 1 | 2013 | 813 | 0.090 |
Why?
| | Critical Illness | 1 | 2017 | 759 | 0.090 |
Why?
| | Swine | 3 | 2018 | 761 | 0.090 |
Why?
| | Carrageenan | 1 | 2011 | 8 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 791 | 0.090 |
Why?
| | Female | 11 | 2019 | 68829 | 0.090 |
Why?
| | Naproxen | 1 | 2011 | 17 | 0.090 |
Why?
| | Gastric Mucosa | 1 | 2011 | 53 | 0.090 |
Why?
| | Stereoisomerism | 1 | 2011 | 98 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 680 | 0.090 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2011 | 80 | 0.090 |
Why?
| | Rats | 3 | 2018 | 5487 | 0.090 |
Why?
| | Ibuprofen | 1 | 2011 | 81 | 0.090 |
Why?
| | Cells, Cultured | 3 | 2019 | 4102 | 0.090 |
Why?
| | Hypoxia | 1 | 2017 | 1087 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1063 | 0.080 |
Why?
| | Edema | 1 | 2011 | 124 | 0.080 |
Why?
| | Male | 11 | 2019 | 63759 | 0.080 |
Why?
| | Cell Line | 2 | 2016 | 2780 | 0.080 |
Why?
| | Plasticizers | 1 | 2019 | 14 | 0.080 |
Why?
| | Succinate Dehydrogenase | 1 | 2019 | 46 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2833 | 0.080 |
Why?
| | Vasoconstrictor Agents | 1 | 2019 | 127 | 0.070 |
Why?
| | Caspases, Initiator | 1 | 2018 | 17 | 0.070 |
Why?
| | Liver X Receptors | 1 | 2018 | 31 | 0.070 |
Why?
| | Multidrug Resistance-Associated Proteins | 1 | 2018 | 37 | 0.070 |
Why?
| | Pulmonary Surfactants | 1 | 2019 | 106 | 0.070 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 213 | 0.070 |
Why?
| | Organ Size | 1 | 2019 | 456 | 0.070 |
Why?
| | Methionine | 1 | 2018 | 155 | 0.070 |
Why?
| | Glycogen Phosphorylase | 1 | 2017 | 4 | 0.070 |
Why?
| | Solutions | 1 | 2018 | 151 | 0.070 |
Why?
| | Caspase 1 | 1 | 2018 | 142 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 232 | 0.070 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 185 | 0.070 |
Why?
| | Azacitidine | 1 | 2018 | 137 | 0.070 |
Why?
| | Biological Transport | 1 | 2018 | 405 | 0.070 |
Why?
| | Cell Respiration | 1 | 2017 | 98 | 0.070 |
Why?
| | Glutathione | 1 | 2019 | 349 | 0.070 |
Why?
| | Mutation | 2 | 2013 | 3706 | 0.070 |
Why?
| | Immune System | 1 | 2018 | 175 | 0.070 |
Why?
| | Trachea | 1 | 2019 | 231 | 0.070 |
Why?
| | Receptors, Interleukin-1 | 1 | 2018 | 218 | 0.070 |
Why?
| | Hemoglobins | 2 | 2018 | 339 | 0.070 |
Why?
| | Lipoproteins | 1 | 2018 | 172 | 0.070 |
Why?
| | Caspases | 1 | 2018 | 245 | 0.070 |
Why?
| | Parenteral Nutrition | 1 | 2018 | 104 | 0.070 |
Why?
| | Hepatocytes | 1 | 2018 | 215 | 0.070 |
Why?
| | Immunologic Factors | 1 | 2019 | 229 | 0.070 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 217 | 0.070 |
Why?
| | Glutamine | 2 | 2017 | 100 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1092 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3185 | 0.070 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2016 | 15 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 216 | 0.060 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2016 | 17 | 0.060 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2016 | 23 | 0.060 |
Why?
| | History, Ancient | 1 | 2016 | 52 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1897 | 0.060 |
Why?
| | Pregnancy | 2 | 2019 | 6423 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2017 | 2378 | 0.060 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 84 | 0.060 |
Why?
| | Cell Lineage | 1 | 2017 | 332 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2018 | 1291 | 0.060 |
Why?
| | Inflammation | 1 | 2016 | 2748 | 0.060 |
Why?
| | Immunoblotting | 1 | 2016 | 306 | 0.060 |
Why?
| | Vasodilation | 1 | 2018 | 476 | 0.060 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 426 | 0.060 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 317 | 0.060 |
Why?
| | Cytokines | 2 | 2017 | 2022 | 0.060 |
Why?
| | Muscle Fatigue | 1 | 2016 | 101 | 0.060 |
Why?
| | Homeostasis | 1 | 2018 | 605 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1501 | 0.060 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 318 | 0.060 |
Why?
| | Peptide Mapping | 1 | 2014 | 64 | 0.060 |
Why?
| | Molecular Probes | 1 | 2014 | 36 | 0.060 |
Why?
| | Cell Survival | 1 | 2017 | 1086 | 0.060 |
Why?
| | Iodoacetamide | 1 | 2013 | 5 | 0.050 |
Why?
| | Methyl Methanesulfonate | 1 | 2013 | 6 | 0.050 |
Why?
| | Ethylmaleimide | 1 | 2013 | 18 | 0.050 |
Why?
| | Isometric Contraction | 1 | 2016 | 187 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 872 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2014 | 77 | 0.050 |
Why?
| | Oxygen | 1 | 2018 | 916 | 0.050 |
Why?
| | HeLa Cells | 1 | 2014 | 611 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2013 | 120 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2016 | 590 | 0.050 |
Why?
| | Hypoglycemia | 1 | 2017 | 427 | 0.050 |
Why?
| | Adult | 5 | 2019 | 35634 | 0.050 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 766 | 0.050 |
Why?
| | Myocardium | 2 | 2019 | 983 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2017 | 2135 | 0.050 |
Why?
| | Pneumonia | 1 | 2017 | 619 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1213 | 0.050 |
Why?
| | Microbiota | 1 | 2018 | 734 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1686 | 0.040 |
Why?
| | Nitrosation | 1 | 2010 | 8 | 0.040 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 28 | 0.040 |
Why?
| | Myoglobin | 1 | 2010 | 12 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2016 | 0.040 |
Why?
| | Guanylate Cyclase | 1 | 2010 | 35 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2010 | 57 | 0.040 |
Why?
| | Catalase | 1 | 2010 | 128 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2017 | 1900 | 0.040 |
Why?
| | Protein Binding | 1 | 2016 | 2123 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3089 | 0.040 |
Why?
| | Aza Compounds | 1 | 2009 | 13 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1416 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 151 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 7 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 27 | 0.040 |
Why?
| | Erythrocyte Deformability | 1 | 2018 | 15 | 0.040 |
Why?
| | Sulfur | 1 | 2019 | 49 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2545 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 92 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2018 | 196 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 191 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2016 | 3384 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 184 | 0.040 |
Why?
| | Hibernation | 1 | 2019 | 74 | 0.040 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 228 | 0.040 |
Why?
| | Water | 1 | 2011 | 442 | 0.040 |
Why?
| | Antagomirs | 1 | 2017 | 12 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2017 | 19 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2018 | 131 | 0.040 |
Why?
| | Crush Injuries | 1 | 2017 | 9 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2018 | 215 | 0.040 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.040 |
Why?
| | Pentose Phosphate Pathway | 1 | 2017 | 51 | 0.040 |
Why?
| | Freezing | 1 | 2017 | 87 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2045 | 0.030 |
Why?
| | Tryptophan | 1 | 2019 | 177 | 0.030 |
Why?
| | Lactates | 1 | 2017 | 85 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 81 | 0.030 |
Why?
| | Reference Standards | 1 | 2017 | 176 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2018 | 455 | 0.030 |
Why?
| | Primates | 1 | 2018 | 120 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 73 | 0.030 |
Why?
| | Mice, Nude | 1 | 2018 | 680 | 0.030 |
Why?
| | Chemical Fractionation | 1 | 2016 | 29 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2018 | 438 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 177 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2018 | 5772 | 0.030 |
Why?
| | Databases, Protein | 1 | 2016 | 61 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 23 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 265 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 697 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3397 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 114 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 199 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 96 | 0.030 |
Why?
| | Proteolysis | 1 | 2016 | 167 | 0.030 |
Why?
| | Apolipoprotein L1 | 1 | 2015 | 13 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2017 | 393 | 0.030 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2017 | 209 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 636 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 587 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 451 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2017 | 216 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 235 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 978 | 0.030 |
Why?
| | Trauma Centers | 1 | 2017 | 402 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 808 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 350 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7066 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 357 | 0.030 |
Why?
| | Fibroblasts | 1 | 2017 | 954 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1951 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2015 | 382 | 0.020 |
Why?
| | Kidney | 1 | 2019 | 1383 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 902 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 926 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 937 | 0.020 |
Why?
| | Middle Aged | 2 | 2016 | 31177 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3062 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3773 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4410 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2271 | 0.020 |
Why?
| | Aged | 1 | 2016 | 22107 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2677 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2008 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 9801 | 0.010 |
Why?
|
|
Haines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|